# Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness

> **NCT05157399** · NA · COMPLETED · sponsor: **Otolith Labs** · enrollment: 28 (actual)

## Conditions studied

- Dizziness
- Vertigo
- Vestibular Migraine
- Vestibular Neuritis
- Labyrinthitis

## Interventions

- **DEVICE:** Otoband
- **DEVICE:** Placebo Device

## Key facts

- **NCT ID:** NCT05157399
- **Lead sponsor:** Otolith Labs
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-04
- **Primary completion:** 2022-08-09
- **Final completion:** 2022-09-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157399, "Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05157399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*